Mechanism-Based Inactivation of Cytochromes P450 2E1 and 2B1 by 5-Phenyl-1-pentyne

By Roberts E.S.   Alworth W.L.   Hollenberg P.F.  

Archives of Biochemistry and Biophysics, Vol. 354, Iss. 2, 1998-06 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

Cytochrome P450 2C11: Escherichia coli Expression, Purification, Functional Characterization, and Mechanism-Based Inactivation of the Enzyme

By Licad-Coles E.   He K.   Yin H.   Correia M.A.  

Archives of Biochemistry and Biophysics, Vol. 338, Iss. 1, 1997-02 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

By Melet A.   Assrir N.   Jean P.   Pilar Lopez-Garcia M.   Marques-Soares C.   Jaouen M.   Dansette P.M.   Sari M-A.   Mansuy D.  

Archives of Biochemistry and Biophysics, Vol. 409, Iss. 1, 2003-01 ,pp. : 80-91

Elsevier

Access to resources Recommend Favorite

Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel

By Nishiya Y.   Hagihara K.   Kurihara A.   Okudaira N.   Farid N.A.   Okazaki O.   Ikeda T.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 836-843

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment

By Venkatakrishnan K.   Obach R. S.   Rostami-Hodjegan A.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1225-1256

Informa Healthcare

Access to resources Recommend Favorite